Activation of the MAPK/Akt/Nrf2-Egr1/HO-1-GCLc axis protects MG-63 osteosarcoma cells against 15d-PGJ2-mediated cell death.
Journal Information
Full Title: Biochem Pharmacol
Abbreviation: Biochem Pharmacol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Competing financial interests "
Funding Disclosure
Evidence found in paper:
"C.K. was funded by the Austrian Science Fund (FWF, W1226-B18) within the “Doctoral College Metabolic and Cardiovascular Disease”. K.K. was funded by the Ph.D. Program “Molecular Medicine” at the Medical University of Graz. This work further received support from FWF, W1241 (“Doctoral College – MOLIN”). We thank L. Frank for technical assistance."
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025